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The State of US Health, 1990-2016
Burden of Diseases, Injuries, and Risk Factors Among US States
The US Burden of Disease Collaborators
INTRODUCTION Several studies havemeasured health outcomes in the United States, but
none have provided a comprehensive assessment of patterns of health by state.
OBJECTIVE To use the results of the Global Burden of Disease Study (GBD) to report trends in
the burden of diseases, injuries, and risk factors at the state level from 1990 to 2016.
DESIGN AND SETTING A systematic analysis of published studies and available data sources
estimates the burden of disease by age, sex, geography, and year.
MAIN OUTCOMES ANDMEASURES Prevalence, incidence, mortality, life expectancy, healthy
life expectancy (HALE), years of life lost (YLLs) due to premature mortality, years lived with
disability (YLDs), and disability-adjusted life-years (DALYs) for 333 causes and 84 risk factors
with 95% uncertainty intervals (UIs) were computed.
RESULTS Between 1990 and 2016, overall death rates in the United States declined from
745.2 (95%UI, 740.6 to 749.8) per 100000 persons to 578.0 (95%UI, 569.4 to 587.1) per
100000 persons. The probability of death among adults aged 20 to 55 years declined in 31
states andWashington, DC from 1990 to 2016. In 2016, Hawaii had the highest life
expectancy at birth (81.3 years) andMississippi had the lowest (74.7 years), a 6.6-year
difference. Minnesota had the highest HALE at birth (70.3 years), andWest Virginia had the
lowest (63.8 years), a 6.5-year difference. The leading causes of DALYs in the United States
for 1990 and 2016 were ischemic heart disease and lung cancer, while the third leading cause
in 1990was low back pain, and the third leading cause in 2016 was chronic obstructive
pulmonary disease. Opioid use disorders moved from the 11th leading cause of DALYs in 1990
to the 7th leading cause in 2016, representing a 74.5% (95%UI, 42.8% to 93.9%) change.
In 2016, each of the following 6 risks individually accounted for more than 5% of
risk-attributable DALYs: tobacco consumption, high bodymass index (BMI), poor diet, alcohol
and drug use, high fasting plasma glucose, and high blood pressure. Across all US states, the
top risk factors in terms of attributable DALYs were due to 1 of the 3 following causes: tobacco
consumption (32 states), high BMI (10 states), or alcohol and drug use (8 states).
CONCLUSIONS AND RELEVANCE There are wide differences in the burden of disease at the
state level. Specific diseases and risk factors, such as drug use disorders, high BMI, poor diet,
high fasting plasma glucose level, and alcohol use disorders are increasing and warrant
increased attention. These data can be used to inform national health priorities for research,
clinical care, and policy.
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P revious studies have reported on health disparitiesin US states and counties.1,2 These studies showedthat health disparities have increased with time.
Recent attention has focused on increased mortality in some
age groups and a decline in life expectancy.3 In addition,
the performance of the US health care system does not match
its level of spending on health and lags behind countries with
similar financial resources.4 For example, in 2014, US life
expectancy ranked 43rd in the world, although the United
States spent the most ($3.0 trillion) on health care, exceeding
the median amount spent by Organisation for Economic
Co-operation and Development countries by 35%.5
Several studies have shown large variations in risk factors
bystateandcounty,andthesevariationshavecontributedtodif-
ferences inhealthoutcomes.6-9 In theGlobalBurdenofDisease
Study2010 (GBD2010)USBurdenofDisease report, the follow-
ingrisk factorswerereportedasthemaincausesassociatedwith
US morbidity and mortality (percent contributed to total dis-
ability-adjusted life-years [DALYs] in 2010): poor diet (14%),
smoking (11%),highbloodpressure (8%), andobesity (11%).10-12
Noneof theprevious studiesofUShealthhavebeenascompre-
hensive as the GBD study.5,13-18 The GBD systematically ac-
counts for differences in data sources and biases and analyzes
levelsandtrendsforcausesandriskfactorswithinthesamecom-
putational framework, whichmaximizes comparability across
states, years, and different age groups by sex. GBD is now con-
ducted on an annual cycle, with GBD 2016 providing updated
estimates of mortality, morbidity, and risk factors in 195 loca-
tions, including the United States, from 1990 to 2016.
The findings of GBD 2016 indicate that while the United
States overall is experiencing improvements in health out-
comes, the patterns of health burden at the state level vary
across geography. Routinely monitoring the trend of burden
of disease at the state level is essential given the vital role of
states inmany aspects of health and social policy19—from the
Medicaidprogram to regulationof private insurers20 and con-
sidering that individual states also experience different eco-
nomic circumstances. The current studyusesGBD2016 to re-
port the change in burden of disease, including injuries and
risk factors at the state level, from 1990 to 2016.
Methods
Overview
TheGBD study is estimated annually and each roundof results
is internally consistent (cause-specific mortality estimates are
summed to match all-cause mortality estimates) and collec-
tively exhaustive (residual categories [“other”] are captured to
enablequantifying totalburden) (Sections 1-5 inSupplement 1).
ThenumbersreportedinthepreviousroundofGBDarenot iden-
tical to those of the current round (GBD 2016) for 2 main rea-
sons.First, since theGBD2010SpecialCommunication regard-
ing US risk factors, there has been further refinement of the
“garbagecoding” (ie, ill-definedcausesofdeath) redistribution
methods (Supplement 1). Second, the new analysis at the state
level changes some of the estimation slightlywhen aggregated
to the national level. GBD 2016 provides a new time series.
The GBD 2016 methodology has been published pre-
viously.5,13-18GBDusesseveralmetricstoreportresults forhealth
loss relatedtospecificdiseases, injuries, andrisk factors:deaths
and death rates, years of life lost (YLLs) due to prematuremor-
tality, prevalence andprevalence rates for sequelae, years lived
with disability (YLDs), and DALYs (Box; Sections 2, 3, and 5 in
Supplement 1 and Appendix Table 2 in Supplement 2). GBD
providesacomprehensiveassessmentofall-causemortalityand
estimates for death due to 264 causes in 195 countries and ter-
ritoriesfrom1990to2016,aswellas333causesofDALYs(Appen-
dixTable2inSupplement2).GBD2016has4levelsofcausesthat
aremutuallyexclusive(AppendixTable3inSupplement2).Level
1has3causes:communicable,maternal,neonatal,andnutritional
disorders;noncommunicablediseases;and injuries.Level2has
21 causes. Levels 3 and4 consist ofmore disaggregated causes.
GBD 2016 documented each step of the estimation processes,
aswellasdatasources, inaccordancewiththeGuidelines forAc-
curateandTransparentHealthEstimatesReporting.21Amorede-
tailedmethodologyisavailableintheappendixtothisarticle(Sec-
tions 8 and 9 in Supplement 1).
Data
Toestimate theUSburdenofdiseaseprevalence, computation
for each sequela beganwith a systematic analysis of published
studies and available data sources providing information on
prevalence, incidence, remission, andexcessmortality, suchas
theNationalHealthandNutritionExaminationSurveys,22 state
inpatient databases,23 the National Ambulatory Medical Care
Survey,24NationalHospitalAmbulatoryMedicalCareSurvey,25
Medical Expenditure Panel Survey,26 National Comorbidity
Survey,27 National Epidemiological Survey onAlcohol andRe-
latedConditions,28National SurveyonDrugUse andHealth,29
US Department of Agriculture Continuing Survey of Food
Intakes,30Marketscan,31NationalHealthInterviewSurvey,32Be-
havioralRiskFactor SurveillanceSystem,33 and theCenters for
DiseaseControl andPreventionDiseaseSurveillanceReports.34
Hospital inpatient data were extracted and used for this
analysis.Moreover, outpatient encounter datawere available
for the United States through aggregate data derived from a
Key Points
Question How have the levels and trends of burden of diseases,
injuries, and risk factors in the United States changed from 1990 to
2016 by state?
Findings This study, involving examination of 333 causes and 84
risk factors, demonstrated that health in the United States
improved from 1990 to 2016, although the drivers of mortality and
morbidity have changed in some states, with specific risk factors
such as drug use disorders, high bodymass index (BMI), and
alcohol use disorders being associated with adverse outcomes. In
5 states, the probability of death between ages 20 and 55 years
has increasedmore than 10% between 1990 and 2016.
Meaning Differences in health outcomes and drivers of morbidity
andmortality at the state level indicate the need for greater
investment in preventive andmedical care across the life course.
The intersection of risk, mortality, andmorbidity in particular
geographic areas needs to be further explored at the state level.
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database of claims information for US private and public in-
surance schemes for the years 2000, 2010, and 2012. GBD
methodology applied several correction factors to account for
bias in health service encounter data from these claims that
were available as aggregated by International Classification of
Diseases (ICD) code and by primary diagnosis only. First, for
chronicdisorders, thestudyestimatedtheratiobetweenpreva-
lence from primary diagnoses and prevalence from all diag-
noses associated with a claim. Second, the claims data were
used togenerate themeannumberof outpatient visits perdis-
order.Similarly, thestudygeneratedper-persondischarge rates
from hospital inpatient data in the United States.
All-CauseMortality and Cause of Death
All-causemortalitywasestimatedbyage,sex,geography,andyear
using6modelingapproaches toassesscause-specificmortality;
the Cause of Death EnsembleModel was used to generate esti-
mates for thevastmajorityofcauses.Thisanalysisuseddeiden-
tified death records from theNational Center for Health Statis-
tics(NCHS)35andpopulationcountsfromtheUSCensusBureau,36
NCHS, and theHumanMortalityDatabase.37 Deaths andpopu-
lationwere tabulatedbycounty,agegroup, sex,year,and(in the
caseofdeathdata)cause.Thecause listdevelopedfor theGBD13
isarrangedhierarchically in4levels.Withineachlevel, thecause
list isdesignedsuch that all deathsareassignedexactly 1 cause.
Aspart of theGBDstudy, amaphasbeendeveloped that allows
ICD-9 and ICD-10 codes to be translated toGBD causes.
Previous studieshavedocumented the existenceof insuf-
ficiently specific or implausible causes of death used in death
registration data that may lead to misleading geographic and
temporal patterns.38 Algorithms developed for the GBDwere
used to reallocate deaths assigned one of these garbage codes
to plausible alternatives.39 First, plausible target causeswere
assigned to each garbage code or groupof garbage codes. Sec-
ond, deathswere reassigned to specified target codes accord-
ing to proportions derived in 1 of 4 ways: (1) published litera-
ture or expert opinion; (2) regressionmodels; (3) according to
the proportions initially observed among targets; and (4) for
HIV/AIDS specifically, by comparison to years before HIV/
AIDS becamewidespread.More detail on each of thesemeth-
ods is provided in Section 2 of Supplement 1.
Basedon standardGBDmethods,YLLswere computedby
multiplying thenumberof deaths fromeach cause in eachage
group by the reference life expectancy at the mean of age of
death among thosewhodied in the age group. TheYLLs com-
putation is based on the precedent set by GBD and uses the
same life table standard for calculatingYLLs inall locationsand
years (essential for comparing estimates of YLLs across loca-
tions and years). The standard ismeant to represent themor-
tality experience of a populationwithminimal excessmortal-
ity using the lowest observed age-specific mortality rates in
2016amongall countrieswith apopulationgreater than5mil-
lion. This standard does not vary with time because for most
populations, the number of YLLs (once normalized for popu-
lation size) is larger in earlier years than in later years due to
improvingsurvival rather thananartifactof thestandardused.
Analysis of Incidence, Prevalence, and YLDs
In this study, incidenceandprevalenceofdiseasesbyage, sex,
cause, year, andgeographywere estimatedusing awide range
ofupdated and standardized analytical procedures.GBDused
DisMod-MR, a Bayesian meta-regression tool, to determine
prevalence and incidence by cause and sequelae.40
Data sources used for quantifying nonfatal outcomes are
available online in the GBD results tool41 and in Section 3 of
Supplement 1. Prevalence of each sequela was multiplied by
thedisabilityweight for the correspondinghealth state to cal-
culate YLDs for the sequela. The sum of all YLDs for relevant
sequelae equated to overall YLDs for each disease. Details on
disabilityweights forGBD2016, includingdata collection and
disability weight construction, are described elsewhere.14
Analysis of DALYs and HALE
FollowingGBD2016methods,nationalandstate-levelDALYswere
computedby summingYLLs andYLDs for each cause, age, and
sex in 1990, 1995, 2000, 2005, 2010, and 2016 (Section 4 in
Supplement 1).DALYswerecomputed for 333causes,with95%
uncertaintyintervals(UIs)capturingtheuncertaintyforbothYLL
andYLD rates.HALEwas calculatedusing the Sullivanmethod
andgenerated95%UIsthat indicateduncertaintyforage-specific
death rates andYLDs per capita for each geography, age group,
sex, andyear.HALEwascalculated for theUnitedStatesandfor
eachindividualstateusingmultiple-decrementlifetablesandes-
timatedYLDsper capita; additionaldetails onHALEmethodol-
ogy are provided in Section 4 in Supplement 1.
Risk Factors
GBD2016used the comparative risk assessment framework to
estimateattributabledeaths,DALYs, and trends inexposureby
agegroup, sex,year, andgeography for risks from1990to2016.
GBD has 84 behavioral, environmental and occupational, and
metabolic risks or clusters of risks (Section 5 in Supplement 1).
Risk-outcomepairswere included in theGBD2016study if they
Box. Glossary of Terms
Disability-adjusted life-years: a summarymetric of population
health.DALYs represent ahealth gapand, as such,measure the state
of apopulation’s health compared to anormative goal. Thegoal is for
individuals to live the standard life expectancy in full health.DALYs
are the sumof2 components: years of life lost (YLLs) andyears lived
withdisability (YLDs).
Healthy life expectancy: the number of years that a person at
a given age can expect to live in good health, taking into account
mortality and disability.
Summary Exposure Value: the relative risk–weighted prevalence of
exposure (developed for Global Burden of Diseases Study 2015).
Years livedwith disability: computed as the prevalence of different
disease sequelae and injury sequelaemultiplied by disability weights
for that sequela. Disability weights are selected on the basis of
surveys of the general population about the health loss associated
with the health state related to the disease sequela.
Years of life lost due to prematuremortality: computed by
multiplying the number of deaths at each age by a standard life
expectancy at that age. The standard selected represents the
normative goal for survival and has been computed based on
the lowest recorded death rates across countries in 2010.
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metWorldCancerResearchFundcriteria forconvincingorprob-
ableevidence.Relative risk (RR)estimateswereextracted from
publishedandunpublished randomizedclinical trials, cohorts,
andpooledcohorts.Riskexposureswereestimatedbasedonpub-
lishedstudies,householdsurveys,USCensusdata,satellitedata,
andother sources.Twomodelingapproaches, aBayesianmeta-
regressionmodelandaspatiotemporalGaussianprocess regres-
sionmodel,weredeveloped for theGBDstudyandused topool
data from different sources, adjust for bias in the data, and in-
corporatepotentialcovariates.GBDusedthecounterfactualsce-
nario of theoretical minimum risk exposure level (ie, the level
for a given risk exposure that couldminimize risk at the popu-
lation level) toattributeburden.Asummaryexposurevaluewas
developedforGBD2015as theRR-weightedprevalenceofexpo-
sure (range, 0 [no excess risk exists in a population] to 1 [popu-
lation is at the highest risk]).16
SEV =
n
i = 1
∑ Pri RRi – 1
RRmax – 1
WherePri is prevalence of category i exposure; RRi is theRRof
the category i; and RRmax is the maximum RR observed (be-
tweencategories).Thisquantity isestimatedforeachagegroup,
sex, geography, and year. In the case of dichotomous expo-
sure, summary exposure value is equal toprevalence. For con-
tinuous risks, summary exposure value is defined as follows:
SEV =
∫
u
x = 1
RR(x) P(x) dx – 1
RRmax – 1
Where (χ) is the density of exposure at level χ of exposure; (χ)
is theRRof the level χ; andRRmax is thehighestRR that is sup-
ported by data and reflects a level in which more than 1% of
thepopulation is exposedglobally. In this study, summary ex-
posure value is reported on a scale from 0% to 100% to em-
phasize that it is risk-weighted prevalence.
To calculate risk-attributable fractions of disease burden
bycause, theeffectsof riskexposure levelsweremodeled,RRs
associated with risk exposure and specific health outcomes
were documented, and counterfactual levels of risk exposure
on estimates of national and state-level deaths, YLLs, YLDs,
and DALYs were computed. Detailed descriptions of the GBD
2016 methods for risk factor assessment and attribution are
published elsewhere (Section 5 in Supplement 1).5,13-18
Decomposition of Changes in Probability of Death
Theprobabilityofdeathwascalculatedfor3summaryage inter-
vals and the cause-specific contributions to each of these sum-
maryindicatorsforages0to20,20to55,and55to90years.These
age groupswere chosen to reflect variations in trends and bur-
den for adolescents, young adults, and older people. For each
probability of death, themultiple decrement life-tablemethod
wasusedtocomputetheprobabilityofdeathfromeachcauseand
the overall contribution of each cause of death to the summary
probability of death. Although discrete age categories from life
table calculationswereused, theagecategories slightlyoverlap
forcalculationsofprobabilityofdeath(ages20yearsand55years;
seeSection6 inSupplement 1).Todecompose thekeydriversof
life loss, theprobabilityofdeathwasdeterminedandexamined
in parallel to the cause fractions for that same age group. Addi-
tional informationonthedecompositionofchanges intheprob-
ability of death, including the formulas used, is available in the
onlinemethods section (Supplement 1).
Sociodemographic Index
GBD2015createdasummary indicator thatcombinesmeasures
of incomeper capita, educational attainment for age 15yearsor
older,andtotal fertility rates.39,42-46This indicator isupdatedfor
eachGBDround.Thecurrentsociodemographic index(SDI)was
usedtocompareobservedpatternsofhealthlosstoexpectedpat-
terns for countries or locationswith similar SDI scores. The SDI
wascomputedsimilarly tothecomputationof thehumandevel-
opmentindextoimproveinterpretability.Eachcomponentofthe
SDIwasweightedequallyandrescaled(range,0[lowestobserved
valueduring1980-2016]to1[highestobservedvalueduring1980-
2016]). In the United States in 2016, the SDI ranged from0.874
inMississippi to 0.978 inWashington, DC (global SDI values in
2016rangedfrom0.268inSomalia to0.978 inWashington,DC).
Results
USMortality and YLLs
Table 1 lists the 25 leading causes of death andprematuremor-
tality from1990to2016. Ischemicheartdisease (IHD); cancerof
thetrachea,bronchus,andlung;chronicobstructivepulmonary
disease;Alzheimerdiseaseandotherdementias; andcancerof
thecolonandrectumwerethe5 leadingcausesofdeath.Despite
a 50.7%decline in age-standardizedmortality and a 50.4%de-
cline inage-standardizedYLLs, IHDremainedthe leadingcause
ofdeathandprematuremortality.Therewasan increase inage-
standardizedmortalityandinage-standardizedYLLsfrom1990
forchronicobstructivepulmonarydisease (13.8%fordeathsand
4.6% for YLLs) and forAlzheimer disease andother dementias
(11.6%fordeathsand5.5%forYLLs).Therewasadecreaseinage-
standardizedmortality and inage-standardizedYLLs for colon
and rectal cancer (29.6%fordeathsand27.9%forYLLs) and for
breastcancer(32.6%fordeathsand36.0%forYLLs).Deathsfrom
endocrine,metabolic, blood, and immunedisorders increased
by 89.1%, and YLLs increased by 60.3% from 1990 to 2016 (an
increaseinrankfrom37in2010to22in2016).Othernotablefind-
ingsseen inTable 1aredeclines indeaths fromself-harmbyfire-
arm(13.2%)andphysical violenceby firearm(28.5%)butan in-
crease in self-harmby othermeans (16.9%).
US YLDs
Table 2 provides the 25 leading diseases and injuries contrib-
uting to YLDs. Low back pain and major depressive disorders
remained the first and second causes of YLDs in 2016. Age-
standardizedratesof lowbackpaindeclinedby12.4%,whileage-
standardized ratesofmajordepressivedisorderdidnot change
from1990.Diabetes,whichwasthethird leadingcauseofYLDs,
hada29.6% increase in age-standardized rates from1990, and
increased inrankfrom8in1990to3 in2016.From1990to2016,
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fallshadan increaseof22.2%inYLDs,opioidusedisordershad
an increaseof 10.9%inYLDs,andasthmahadadeclineof 12.4%
in age-standardized YLD rates. Other notable findings include
anincreaseof9.7%inage-standardizedYLDratesofhearing loss
due to aging and other causes.
USDALYs
Figure 1 shows the25 leadingcausesofDALYs in 1990and2016
with theirmeanpercentage changeduring theperiod. IHDand
lungcancerwere the leadingcausesofDALYs inbothyears, but
the age-standardized rate declined between 1990 and 2016 by
49.7%forIHDandby32.5%forlungcancer.Theage-standardized
DALYrate for chronicobstructivepulmonarydisease (the third
leadingcausein2016) increasedby5.5%between1990and2016,
and fordiabetes (the fourth leadingcause in2016), it increased
by11%.Diabetes increased fromthesixth leadingcause in 1990
tothefourthin2016,while lowbackpaindeclinedfromthethird
leadingcausetothefifth.Three leadingcausesofDALYShadde-
clinesinage-standardizedratesfrom1990to2016:motorvehicle
road injuries (by35.0%),breast cancer (by34.3%), andcolorec-
talcancer(by27.4%).FourleadingcausesofDALYShadincreases
in age-standardized rates from 1990 to 2016: opioid use disor-
ders (by 47.9%), chronic kidney disease (by 44.3%), self-harm
by othermeans (by 20.3%), and falls (by 19.0%).
US Risk Factor Estimates
Figure2showsthenumberofdeathsandthepercentageofDALYs
from17 risk factors in2016.Diet, tobaccouse, andhigh systolic
bloodpressurewere the leadingcausesofdeathswhile tobacco
use,highbodymass index,anddietwerethe leadingrisk factors
for DALYs. For example, dietary risks accounted for 529299
deaths in2016,with83.9%of thesedeathsdue to cardiovascu-
lar diseases, and the remainder due to a combination of neo-
plasmsanddiabetes,andtourogenital,blood,andendocrinedis-
eases. Alcohol and drug use were the eighth leading cause of
deathandthefourth leadingcauseofDALYs. In2016,eachof the
6 following risksaccounted formore than5%ofDALYs: tobacco
consumption,highbodymass index,diet, alcoholanddruguse,
high fasting plasma glucose levels, and high blood pressure.
Attribution of DALYs to Risk Factors
In 2016, 44.9%of total DALYs in theUnited Stateswere attrib-
utable to risk factors. Behavioral risk factors accounted for the
largest percentage of the attributable fraction ofDALYsdue to
all causes (43.5%), followed by metabolic (22.7%), and envi-
ronmental and occupational risks (3.7%) (Supplement 2).
Individual State Data
GBD 2016 showed substantial variations in the burden of dis-
eases, injuries, and risk factors by state. Therewasalso avaria-
tion in trends by age, sex, and state (key findings and results
of burden by state in Supplement 3).
Life Expectancy and HALE
Life expectancy andHALEat birth for both sexes combined for
theUnitedStates,all50states,andforWashington,DCareshown
inTable3.Hawaiihadthehighest lifeexpectancyatbirth in2016
(81.3 years [95% UI, 80.6 to 81.9]), while Mississippi had the
lowest (74.7 years [95%UI, 73.5 to 76.1]; a 6.6-year difference).
OtherstateswithhighlifeexpectancywereCalifornia(80.9years
Table2.USYearsLivedWithDisability (YLDs)Rank,Rate, andPercentageChange for the25LeadingCausesofDisability and Injury, 1990and2016
Diseases and Injuries
YLD Rank No. of YLDs, in Thousands (95% Uncertainty Interval) % Change (95% Uncertainty Interval)
1990 2016 1990 2016 YLDs Age-Standardized YLD Rate
Low back pain 1 1 2461.1 (1732.3 to 3228.8) 3069.1 (2211.0 to 3989.6) 24.7 (10.9 to 39.6) −12.4 (−22.3 to −1.9)
Major depressive disorder 2 2 1726.2 (1192.3 to 2330.5) 2193.0 (1507.6 to 2990.5) 27.0 (21.6 to 32.7) 0.1 (−4.1 to 3.7)
Diabetes mellitus 8 3 1040.2 (716.1 to 1450.3) 2142.9 (1496.1 to 2932.8) 106.0 (92.9 to 119.0) 29.6 (21.2 to 37.5)
Other musculoskeletal disorders 4 4 1573.5 (1076.0 to 2193.9) 2076.5 (1423.2 to 2843.1) 32.0 (22.5 to 42.0) −2.3 (−8.7 to 4.3)
Migraine 3 5 1580.3 (1013.0 to 2205.4) 2010.1 (1296.4 to 2814.8) 27.2 (25.3 to 29.1) −1.4 (−2.8 to −0.1)
Neck pain 6 6 1281.8 (880.4 to 1788.4) 1982.6 (1381.1 to 2704.7) 54.7 (39.2 to 73.3) 2.9 (−7.5 to 15.0)
Anxiety disorders 5 7 1341.7 (940.7 to 1813.1) 1755.0 (1229.6 to 2383.4) 30.8 (25.7 to 36.0) 0.6 (−3.2 to 4.5)
Opioid use disorders 7 8 1256.2 (892.8 to 1588.8) 1638.9 (1144.0 to 2097.4) 30.5 (23.3 to 37.4) 10.9 (4.2 to 17.2)
Age-related and other hearing loss 9 9 886.9 (599.0 to 1269.5) 1528.0 (1035.7 to 2157.1) 72.3 (67.3 to 78.3) 9.7 (6.6 to 13.4)
Falls 11 10 722.7 (487.8 to 1010.2) 1389.1 (960.0 to 1922.6) 92.2 (83.8 to 102.6) 22.2 (17.7 to 27.8)
Chronic obstructive pulmonary disease 12 11 674.4 (585.1 to 743.9) 1184.6 (1035.1 to 1307.3) 75.7 (66.8 to 84.9) 7.4 (2.0 to 12.9)
Osteoarthritis 14 12 573.5 (377.6 to 829.6) 1005.0 (659.5 to 1448.2) 75.2 (68.5 to 82.6) 7.9 (3.7 to 12.5)
Acne vulgaris 10 13 855.9 (573.6 to 1236.1) 992.6 (668.0 to 1441.4) 16.0 (14.3 to 17.8) −1.5 (−3.0 to 0.2)
Dermatitis 13 14 659.8 (405.3 to 1032.9) 830.2 (515.1 to 1296.5) 25.8 (24.0 to 28.0) 1.2 (0.3 to 2.2)
Ischemic stroke 18 15 464.0 (321.3 to 607.7) 716.9 (500.9 to 912.7) 54.5 (41.5 to 64.9) −3.5 (−11.2 to 2.9)
Schizophrenia 17 16 503.3 (365.0 to 627.7) 685.2 (506.9 to 847.9) 36.1 (32.7 to 39.5) 1.7 (−0.0 to 3.5)
Edentulism and severe tooth loss 19 17 458.0 (301.1 to 649.2) 662.2 (432.6 to 936.6) 44.6 (42.9 to 46.3) −8.6 (−9.6 to −7.4)
Alcohol use disorders 15 18 558.2 (380.7 to 771.4) 633.9 (440.3 to 852.1) 13.6 (5.0 to 23.7) −8.6 (−15.2 to −1.1)
Alzheimer disease and other dementias 23 19 360.8 (253.3 to 476.0) 597.6 (431.4 to 774.4) 65.6 (54.5 to 78.4) −1.1 (−7.0 to 5.7)
Rheumatoid arthritis 25 20 350.2 (245.4 to 464.0) 592.4 (412.6 to 775.9) 69.1 (63.1 to 75.5) 10.1 (6.4 to 14.1)
Asthma 16 21 522.1 (342.5 to 744.9) 591.0 (393.8 to 832.4) 13.2 (7.5 to 19.2) −12.4 (−17.1 to −7.6)
Other mental and substance use
disorders
20 22 421.2 (288.4 to 601.1) 566.1 (390.0 to 804.1) 34.4 (32.9 to 35.9) 0.5 (−0.5 to 1.6)
Dysthymia 22 23 375.1 (254.3 to 548.2) 522.0 (352.7 to 753.3) 39.2 (31.7 to 47.2) 2.5 (−2.7 to 8.1)
Bipolar disorder 21 24 376.4 (236.7 to 545.7) 489.1 (309.6 to 703.2) 29.9 (27.9 to 32.1) −0.4 (−1.9 to 1.0)
Psoriasis 24 25 351.9 (253.0 to 459.4) 488.2 (350.9 to 635.5) 38.7 (36.9 to 40.6) 1.9 (0.6 to 3.2)
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[95%UI, 79.9 to81.9]),Connecticut (80.8years [95%UI, 79.7 to
81.8]),Minnesota (80.8years [95%UI, 80.0 to81.6]),NewYork
(80.5 years [95% UI, 79.4 to 81.6]), Massachusetts (80.4 years
[95% UI, 79.6 to 81.1]), Colorado (80.2 years [95% UI, 79.4 to
80.9]),NewJersey(80.2years [95%UI,79.3to80.9]),andWash-
ington (80.2years [95%UI, 79.5 to80.8]).Other stateswith low
life expectancywereWest Virigina (75.3 years [95%UI, 74.4 to
76.0]),Alabama(75.4years[95%UI,74.1to76.7]),Louisiana(75.6
years [95%UI,74.9to76.4]),Oklahoma(75.7years [95%UI,75.0
to76.4]),Arkansas (75.8years [95%UI, 74.9 to76.8]), andKen-
tucky(75.8years [95%UI,74.9 to76.6]). In2016,Minnesotahad
thehighestHALEatbirthwith70.3years,whileWestVirginiahad
the lowest at 63.8 years, a 6.5-year difference. Only 2 states,
MinnesotaandHawaii,hadHALEvaluesgreater than70.0years
atbirth in2016. In termsof lifeexpectancy in2016,only9states
had life expectancy values greater than 80.0 years.
Male lifeexpectancyandHALEatbirth for theUnitedStates
overall, for all states, and for Washington, DC, are shown in
Table4.Minnesotahadthehighest lifeexpectancy in2016 (78.7
years [95%UI, 77.5 to79.8]) andHALE (69.1years [95%UI,66.3
to71.9]), followedbyCalifornia (lifeexpectancy,78.6years [95%
UI, 77.2 to 80.1]; and HALE, 68.6 years [95% UI, 65.5 to 71.6]).
Mississippihadthe lowest lifeexpectancyformales in2016(71.8
years [95% UI, 70.1 to 73.8]) and ranked 49th for HALE (63.0
years [95%UI, 60.3 to 65.6]), whileWest Virginia had the low-
est HALE (62.2 years [95% UI, 54.9 to 65.0]) and ranked 49th
for life expectancy (72.7 years [95%UI, 71.5 to 73.9).
Female life expectancy and HALE at birth for the United
States,forallstates,andforWashington,DC,areshowninTable5.
Hawaiihad thehighest life expectancy in2016 (84.1years [95%
UI,83.2 to85.0) andHALE(71.9years [95%UI,68.3 to75.1), fol-
lowedby life expectancy forCalifornia (83.1 years [95%UI,81.8
to84.3])andlifeexpectancyforConnecticut (83.1years [95%UI,
81.7 to84.4]); thesecondhighestHALEwas forMinnesota (71.4
years [95%UI, 68.3 to 74.5]).Mississippi had the lowest life ex-
pectancyforfemales(77.7years[95%UI,76.1to79.6]),whileWest
Virginiahadthe lowestHALE(65.5years [95%UI,61.9 to68.5]).
Table 6 presents the age-standardized death rates, age-
standardizedYLLrates, andage-standardizedYLDrates in1990
and 2016 and their ranks by state. The 3measurements varied
widelybetweenthestates in2016, rangingfrom767.6deathsper
100000 inMississippi to 465.8 deaths per 100000 in Hawaii,
from17775.9YLLsper100000inMississippi to9901.8YLLsper
100000 inMinnesota, and from 13090.6 YLDs per 100000 in
WestVirginia to 10582.8YLDsper 100000 inMinnesota.Ano-
table improvementwasobserved inWashington,DC(decreases
from1042.7deathsper100000to603.3deathsper100000,from
29536.9YLLSper100000to13635.9YLLsper100000,andfrom
12230.8YLDsper 100000 to 11421.1 YLDsper 100000) and in
California (decreases from 719.1 deaths per 100000 to 491.7
Figure1.Top25CausesofDisability-AdjustedLife-Years (DALYs)and%Change inNumberofDALYs,All-AgeDALYs,andAge-StandardizedDALYs, 1990-2016
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deaths per 100000, from 15903.4YLLSper 100000 to9987.0
YLLsper100000,andfrom11170.5YLDsper100000to10990.4
YLDsper100000).Decreases inmortalityandincreases inmor-
bidityweremoreapparentinOhio(from761.5deathsper100000
to644.1deathsper 100000, from16349.6YLLsper 100000to
13853.3YLLsper100000,andfrom12009.0YLDsper100000
to12334.7YLDsper100000)andinOklahoma(from773.8deaths
per100000to725.3deathsper100000, from17062.7YLLsper
100000 to 16379.3 YLLs per 100000, and from 12036.5 YLDs
per100000to12549.7YLDsper100000).Theage-standardized
deathratesandage-standardizedYLLratesdeclinedinall states,
butthe levelofdeclinefordeathsrangedfrom6.3%inOklahoma
to 42.1% in Washington, DC and the level of decline for YLLs
ranged from 4.0% for Oklahoma to 53.8% forWashington, DC.
Age-standardizedYLDrates increasedby4.4%forWestVirginia
anddeclined by 6.6% forWashington, DC.
Decomposition of the Probability of Death by Age and State
The decomposition of change in the probability of death from
birth toage20years, ages20to55years, andages55 to90years
areshowninFigure3,Figure4,andFigure5.FortheUnitedStates
andeachstate, these figures showthechange in theprobability
of death from 1990 to 2016. In addition, these figures show
changes in the probability of death over the interval due to
changes in causes of death (GBD cause hierarchy level 2). The
change in the probability of death from birth to age 20 years
Figure 2. Number of Deaths and Percentage of Disability-Adjusted Life-Years Related to the 17 Leading Risk Factors in the United States, 2016
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Table 3. Life Expectancy and Healthy Life Expectancy at Birth for the United States, the 50 States, andWashington, DC, 1990 and 2016, Both Sexes
Location
Life Expectancy at Birth, y Healthy Life Expectancy at Birth, y
1990 2016 1990 2016
Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank
United States 75.5 (75.4-75.5) 78.9 (78.7-79.0) 65.3 (62.4-67.9) 67.7 (64.5-70.5) .
Alabama 73.7 (73.3-74.2) 47 75.4 (74.1-76.7) 49 63.7 (61.0-66.3) 48 64.6 (61.5-67.6) 48
Alaska 75.0 (74.5-75.6) 34 78.1 (76.9-79.4) 34 65.0 (62.2-67.6) 32 67.3 (64.2-70.3) 33
Arizona 76.1 (75.7-76.6) 22 79.5 (78.6-80.4) 19 65.4 (62.4-68.1) 24 67.7 (64.3-70.8) 27
Arkansas 74.4 (74.0-74.8) 43 75.8 (74.9-76.8) 45 64.5 (61.7-67.1) 40 65.5 (62.6-68.2) 44
California 75.9 (75.5-76.4) 24 80.9 (79.9-81.9) 2 66.1 (63.3-68.6) 19 69.9 (66.6-72.8) 3
Colorado 77.1 (76.7-77.4) 6 80.2 (79.4-80.9) 7 66.7 (63.7-69.4) 10 68.9 (65.7-71.8) 9
Connecticut 77.0 (76.6-77.5) 7 80.8 (79.7-81.8) 3 66.5 (63.5-69.1) 12 69.0 (65.7-72.1) 6
Delaware 74.9 (74.5-75.3) 37 78.6 (77.9-79.4) 28 64.6 (61.7-67.2) 39 67.2 (64.0-70.1) 34
Florida 76.0 (75.6-76.4) 23 79.6 (78.6-80.5) 15 65.5 (62.6-68.2) 23 67.9 (64.5-71.0) 24
Georgia 73.8 (73.2-74.3) 46 77.4 (76.2-78.4) 41 63.9 (61.0-66.5) 44 66.6 (63.5-69.5) 38
Hawaii 78.5 (78.2-78.9) 1 81.3 (80.6-81.9) 1 68.2 (65.2-70.9) 1 70.1 (66.9-73.0) 2
Idaho 77.0 (76.6-77.5) 8 79.1 (78.1-80.3) 23 66.4 (63.5-69.0) 13 67.9 (64.5-70.9) 25
Illinois 75.0 (74.7-75.4) 35 79.1 (78.4-79.8) 24 65.2 (62.5-67.7) 29 68.3 (65.3-71.0) 18
Indiana 75.4 (75.0-75.9) 27 77.2 (76.0-78.5) 42 65.1 (62.2-67.7) 31 66.0 (62.9-69.0) 42
Iowa 77.3 (77.0-77.7) 5 79.5 (78.6-80.4) 17 67.4 (64.6-70.0) 4 68.9 (65.8-71.7) 7
Kansas 76.8 (76.4-77.3) 12 78.5 (77.3-79.7) 30 66.8 (64.0-69.3) 8 67.8 (64.8-70.7) 26
Kentucky 74.4 (74.1-74.8) 42 75.8 (74.9-76.6) 46 63.7 (60.8-66.5) 45 64.3 (61.2-67.3) 50
Louisiana 73.3 (73.0-73.7) 49 75.6 (74.9-76.4) 48 63.2 (60.4-65.8) 50 65.0 (62.0-67.7) 46
Maine 76.3 (75.9-76.7) 21 79.0 (78.3-79.7) 26 66.1 (63.3-68.6) 17 68.0 (65.0-70.9) 21
Maryland 74.8 (74.5-75.2) 38 79.2 (78.5-79.9) 21 64.7 (61.8-67.3) 37 68.0 (65.0-70.7) 22
Massachusetts 76.7 (76.3-77.1) 15 80.4 (79.6-81.1) 6 66.1 (63.2-68.7) 18 68.9 (65.6-71.8) 8
Michigan 75.2 (74.9-75.5) 33 78.0 (77.3-78.7) 35 64.9 (62.0-67.6) 35 67.0 (63.9-69.9) 35
Minnesota 77.8 (77.4-78.2) 3 80.8 (80.0-81.6) 4 67.9 (65.1-70.4) 2 70.3 (67.4-73.0) 1
Mississippi 73.1 (72.6-73.6) 50 74.7 (73.5-76.1) 51 63.7 (61.0-66.1) 46 64.9 (62.1-67.6) 47
Missouri 75.3 (75.0-75.7) 31 77.4 (76.8-78.2) 40 65.3 (62.4-67.9) 28 66.5 (63.4-69.2) 39
Montana 76.4 (75.9-76.9) 18 78.9 (77.7-80.1) 27 66.0 (63.1-68.6) 20 67.7 (64.5-70.9) 28
Nebraska 76.9 (76.5-77.3) 10 79.4 (78.8-80.1) 20 67.0 (64.2-69.5) 7 68.8 (65.7-71.5) 12
Nevada 74.5 (74.1-74.9) 41 78.1 (77.3-79.0) 33 64.3 (61.5-67.0) 41 66.9 (63.9-69.7) 36
New Hampshire 76.7 (76.4-77.1) 14 79.9 (79.2-80.6) 11 66.2 (63.3-68.8) 16 68.5 (65.3-71.4) 14
New Jersey 75.4 (75.1-75.8) 26 80.2 (79.3-80.9) 8 65.3 (62.5-67.9) 25 68.8 (65.7-71.8) 10
New Mexico 75.9 (75.4-76.4) 25 77.8 (76.5-79.1) 38 65.3 (62.4-68.0) 26 66.3 (63.0-69.4) 40
New York 74.7 (74.3-75.2) 39 80.5 (79.4-81.6) 5 64.3 (61.4-67.0) 42 68.5 (65.1-71.6) 15
North Carolina 74.7 (74.4-75.1) 40 77.9 (77.3-78.6) 37 64.9 (62.2-67.5) 34 67.4 (64.4-70.1) 32
North Dakota 77.7 (77.2-78.2) 4 79.8 (78.8-80.9) 12 67.6 (64.7-70.1) 3 68.8 (65.6-71.8) 11
Ohio 75.4 (75.0-75.7) 29 77.5 (76.8-78.2) 39 64.9 (62.0-67.6) 33 66.1 (62.9-69.0) 41
Oklahoma 75.0 (74.6-75.4) 36 75.7 (75.0-76.4) 47 64.6 (61.7-67.2) 38 64.5 (61.4-67.4) 49
Oregon 76.3 (76.0-76.7) 19 79.5 (78.9-80.2) 16 66.0 (63.1-68.5) 21 68.4 (65.3-71.2) 17
Pennsylvania 75.4 (75.1-75.7) 28 78.5 (77.9-79.2) 29 64.7 (61.8-67.5) 36 66.8 (63.7-69.8) 37
Rhode Island 76.6 (76.1-77.0) 17 79.6 (78.6-80.7) 13 65.8 (62.8-68.5) 22 68.1 (64.9-71.2) 20
South Carolina 73.7 (73.2-74.2) 48 76.8 (75.7-77.8) 43 63.6 (60.8-66.2) 49 65.8 (62.7-68.7) 43
South Dakota 76.9 (76.4-77.4) 11 79.1 (78.1-80.1) 25 67.1 (64.3-69.6) 6 68.4 (65.3-71.4) 16
Tennessee 74.3 (74.0-74.7) 44 76.1 (75.5-77.0) 44 64.2 (61.4-66.8) 43 65.4 (62.3-68.2) 45
Texas 75.3 (74.8-75.6) 32 78.5 (77.8-79.3) 31 65.3 (62.5-67.9) 27 67.4 (64.4-70.3) 29
Utah 77.9 (77.6-78.3) 2 79.6 (79.0-80.3) 14 67.1 (64.1-69.8) 5 68.2 (64.9-71.1) 19
Vermont 76.6 (76.2-77.0) 16 79.9 (79.2-80.7) 10 66.4 (63.5-69.0) 14 69.0 (65.9-71.8) 5
Virginia 75.3 (75.0-75.7) 30 79.2 (78.5-79.9) 22 65.2 (62.3-67.8) 30 68.0 (64.9-70.8) 23
Washington 76.8 (76.5-77.2) 13 80.2 (79.5-80.8) 9 66.5 (63.7-69.1) 11 69.1 (65.8-71.9) 4
West Virginia 74.3 (74.0-74.7) 45 75.3 (74.4-76.0) 50 63.7 (60.7-66.3) 47 63.8 (60.7-66.7) 51
Wisconsin 76.9 (76.6-77.3) 9 79.5 (78.8-80.1) 18 66.8 (63.9-69.3) 9 68.6 (65.4-71.5) 13
Wyoming 76.3 (75.8-76.8) 20 78.4 (77.2-79.5) 32 66.2 (63.3-68.8) 15 67.4 (64.1-70.4) 30
Washington, DC 68.4 (67.7-69.0) 51 78.0 (76.8-79.1) 36 59.1 (56.6-61.6) 51 67.4 (64.4-70.3) 31
Abbreviation: UI, uncertainty interval.
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Table 4. Life Expectancy and Healthy Life Expectancy at Birth for the United States, the 50 States, andWashington, DC, 1990 and 2016, Males
Location
Life Expectancy at Birth, y Healthy Life Expectancy at Birth, y
1990 2016 1990 2016
Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank
United States 71.9 (71.8-72.1) 76.5 (76.2-76.7) 63.0 (60.5-65.2) 66.3 (63.5-68.8)
Alabama 69.7 (69.1-70.4) 48 72.6 (70.8-74.5) 50 61.1 (58.6-63.4) 47 63.0 (60.1-65.8) 48
Alaska 71.9 (71.0-72.6) 31 75.9 (74.2-77.7) 33 63.0 (60.5-65.4) 29 66.2 (63.3-69.2) 31
Arizona 72.7 (72.1-73.3) 22 77.1 (75.9-78.5) 20 63.2 (60.6-65.6) 23 66.5 (63.3-69.4) 27
Arkansas 70.6 (70.0-71.2) 44 73.3 (71.8-74.7) 45 62.0 (59.6-64.4) 41 64.1 (61.5-66.5) 44
California 72.6 (72.0-73.3) 23 78.6 (77.2-80.1) 2 63.9 (61.5-66.2) 20 68.6 (65.5-71.6) 2
Colorado 73.9 (73.4-74.5) 6 78.1 (77.0-79.1) 6 64.9 (62.3-67.3) 6 67.8 (65.0-70.6) 5
Connecticut 73.7 (73.1-74.4) 10 78.4 (76.7-79.9) 4 64.3 (61.6-66.7) 15 67.6 (64.5-70.6) 8
Delaware 71.7 (71.2-72.3) 33 76.2 (75.1-77.4) 29 62.6 (60.0-64.9) 35 65.8 (63.0-68.5) 33
Florida 72.3 (71.7-72.9) 25 77.0 (75.4-78.3) 22 63.1 (60.6-65.4) 27 66.4 (63.3-69.4) 28
Georgia 69.8 (69.1-70.6) 46 74.8 (73.1-76.3) 42 61.3 (58.8-63.5) 45 65.2 (62.2-68.0) 38
Hawaii 75.5 (75.0-76.1) 1 78.4 (77.4-79.4) 3 66.3 (63.7-68.8) 1 68.3 (65.3-71.1) 3
Idaho 74.0 (73.3-74.7) 5 77.2 (75.6-78.8) 16 64.6 (62.0-67.0) 12 67.0 (63.8-70.0) 19
Illinois 71.5 (70.9-72.0) 37 76.6 (75.5-77.6) 26 62.9 (60.5-65.1) 31 66.8 (64.0-69.4) 21
Indiana 72.0 (71.4-72.7) 28 74.8 (73.1-76.5) 41 63.1 (60.5-65.4) 28 64.8 (61.9-67.7) 40
Iowa 73.9 (73.3-74.5) 7 77.2 (76.0-78.3) 18 65.2 (62.7-67.5) 5 67.6 (64.8-70.1) 7
Kansas 73.5 (72.8-74.1) 13 76.1 (74.4-77.9) 31 64.7 (62.3-67.0) 10 66.5 (63.7-69.5) 25
Kentucky 70.8 (70.3-71.3) 42 73.2 (72.0-74.4) 47 61.3 (58.7-63.8) 44 62.8 (59.9-65.7) 50
Louisiana 69.4 (68.8-69.9) 49 72.9 (71.8-74.0) 48 60.7 (58.3-62.9) 50 63.3 (60.7-65.8) 47
Maine 72.9 (72.4-73.5) 21 76.5 (75.4-77.5) 27 64.0 (61.5-66.2) 18 66.5 (63.6-69.2) 26
Maryland 71.4 (70.9-71.9) 38 76.8 (75.8-77.7) 24 62.5 (60.1-64.8) 37 66.7 (63.9-69.4) 22
Massachusetts 73.3 (72.8-73.9) 14 77.9 (76.9-78.9) 9 63.9 (61.3-66.4) 21 67.4 (64.3-70.1) 12
Michigan 71.9 (71.4-72.3) 32 75.6 (74.7-76.7) 35 62.8 (60.3-65.1) 34 65.6 (62.8-68.4) 35
Minnesota 74.5 (74.0-75.0) 3 78.7 (77.5-79.8) 1 65.9 (63.5-68.1) 2 69.1 (66.3-71.9) 1
Mississippi 69.0 (68.3-69.7) 50 71.8 (70.1-73.8) 51 60.9 (58.6-63.0) 49 63.0 (60.3-65.6) 49
Missouri 71.6 (71.0-72.1) 34 74.9 (73.9-76.0) 40 62.9 (60.5-65.2) 30 65.1 (62.2-67.6) 39
Montana 73.2 (72.5-73.9) 18 76.8 (75.1-78.7) 23 64.1 (61.4-66.3) 17 66.6 (63.5-69.8) 23
Nebraska 73.6 (73.0-74.0) 12 77.2 (76.1-78.1) 19 64.9 (62.5-67.1) 7 67.5 (64.7-70.1) 9
Nevada 71.3 (70.7-71.8) 39 75.9 (74.6-77.1) 34 62.3 (59.8-64.6) 40 65.7 (62.9-68.4) 34
New Hampshire 73.6 (73.1-74.2) 11 77.7 (76.6-78.7) 11 64.2 (61.6-66.5) 16 67.1 (64.3-70.0) 17
New Jersey 72.2 (71.6-72.7) 26 77.8 (76.6-78.9) 10 63.1 (60.6-65.5) 24 67.3 (64.4-70.1) 14
New Mexico 72.4 (71.7-73.2) 24 75.0 (73.1-76.9) 39 63.1 (60.5-65.6) 25 64.7 (61.4-67.9) 42
New York 70.9 (70.3-71.6) 40 78.1 (76.6-79.7) 5 61.7 (59.2-64.1) 42 67.1 (64.0-70.1) 16
North Carolina 70.9 (70.4-71.3) 41 75.4 (74.4-76.4) 36 62.3 (59.9-64.5) 39 65.9 (63.2-68.4) 32
North Dakota 74.2 (73.6-74.9) 4 77.2 (75.7-78.8) 15 65.5 (63.0-67.7) 3 67.4 (64.3-70.2) 13
Ohio 72.1 (71.7-72.6) 27 75.1 (74.0-76.1) 37 62.9 (60.3-65.1) 33 64.8 (61.8-67.4) 41
Oklahoma 71.6 (71.0-72.1) 35 73.2 (72.1-74.4) 46 62.5 (60.0-64.8) 36 63.3 (60.5-66.1) 46
Oregon 73.2 (72.7-73.7) 17 77.4 (76.5-78.3) 13 63.9 (61.3-66.3) 19 67.2 (64.5-69.9) 15
Pennsylvania 71.9 (71.5-72.4) 29 76.0 (74.9-77.0) 32 62.4 (59.8-64.8) 38 65.3 (62.5-68.0) 37
Rhode Island 73.1 (72.5-73.7) 19 77.2 (75.6-78.5) 17 63.6 (61.0-66.1) 22 66.6 (63.7-69.6) 24
South Carolina 69.8 (69.0-70.5) 47 74.2 (72.5-75.9) 43 61.0 (58.5-63.3) 48 64.3 (61.4-67.1) 43
South Dakota 73.2 (72.6-73.9) 16 76.7 (75.1-78.2) 25 64.7 (62.2-66.9) 11 67.1 (64.2-70.0) 18
Tennessee 70.5 (70.0-71.0) 45 73.5 (72.5-74.7) 44 61.6 (59.2-63.9) 43 63.8 (61.0-66.4) 45
Texas 71.5 (70.9-72.1) 36 76.1 (75.0-77.3) 30 62.9 (60.4-65.2) 32 66.2 (63.5-69.0) 30
Utah 75.0 (74.5-75.5) 2 77.9 (77.0-78.9) 8 65.5 (62.8-67.9) 4 67.5 (64.7-70.2) 10
Vermont 73.3 (72.8-73.9) 15 77.6 (76.4-78.7) 12 64.3 (61.7-66.6) 14 67.7 (64.8-70.3) 6
Virginia 71.9 (71.4-72.3) 30 77.0 (76.0-78.0) 21 63.1 (60.6-65.4) 26 67.0 (64.1-69.6) 20
Washington 73.8 (73.3-74.3) 8 78.1 (77.1-79.1) 7 64.8 (62.2-67.0) 9 68.1 (65.1-70.8) 4
West Virginia 70.6 (70.1-71.2) 43 72.7 (71.5-73.9) 49 61.2 (58.6-63.5) 46 62.2 (59.4-65.0) 51
Wisconsin 73.7 (73.2-74.2) 9 77.3 (76.2-78.2) 14 64.8 (62.3-67.1) 8 67.4 (64.6-70.1) 11
Wyoming 73.1 (72.4-73.8) 20 76.2 (74.6-77.8) 28 64.3 (61.7-66.7) 13 66.3 (63.2-69.3) 29
Washington, DC 62.3 (61.4-63.3) 51 75.1 (73.4-76.6) 38 54.5 (52.3-56.8) 51 65.5 (62.6-68.3) 36
Abbreviation: UI, uncertainty interval.
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Table 5. Life Expectancy and Healthy Life Expectancy at Birth for the United States, the 50 States, andWashington, DC, 1990 and 2016, Females
Location
Life Expectancy at Birth, y Healthy Life Expectancy at Birth, y
1990 2016 1990 2016
Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank
United States 78.9 (78.8-79.0) 81.2 (81.0-81.5) 67.5 (64.2-70.4) 69.0 (65.5-72.1)
Alabama 77.6 (77.0-78.3) 46 78.1 (76.6-79.7) 49 66.2 (63.0-69.1) 46 66.2 (62.7-69.5) 48
Alaska 78.8 (78.0-79.5) 28 80.5 (78.9-82.1) 36 67.4 (64.2-70.3) 31 68.5 (65.0-72.0) 34
Arizona 79.7 (79.1-80.2) 19 81.9 (80.7-83.0) 15 67.7 (64.4-70.8) 25 69.0 (65.2-72.4) 25
Arkansas 78.2 (77.6-78.8) 39 78.5 (77.3-79.8) 45 66.9 (63.8-69.8) 34 67.1 (63.7-70.1) 44
California 79.2 (78.7-79.9) 25 83.1 (81.8-84.3) 2 68.2 (65.1-71.0) 16 71.1 (67.7-74.3) 3
Colorado 80.0 (79.6-80.5) 11 82.3 (81.3-83.2) 9 68.4 (65.1-71.5) 11 69.9 (66.3-73.1) 13
Connecticut 80.1 (79.5-80.7) 9 83.1 (81.7-84.4) 3 68.4 (65.2-71.4) 12 70.4 (66.8-73.9) 4
Delaware 77.9 (77.4-78.4) 45 81.0 (80.0-82.0) 29 66.4 (63.2-69.4) 44 68.6 (65.2-71.8) 32
Florida 79.7 (79.2-80.2) 16 82.2 (81.1-83.4) 11 67.9 (64.6-71.0) 22 69.4 (65.8-72.8) 21
Georgia 77.5 (77.0-78.2) 47 79.8 (78.2-81.4) 41 66.4 (63.2-69.3) 45 68.1 (64.6-71.1) 38
Hawaii 81.8 (81.3-82.3) 1 84.1 (83.2-85.0) 1 70.2 (67.0-73.1) 1 71.9 (68.3-75.1) 1
Idaho 80.1 (79.5-80.8) 8 81.2 (79.8-82.5) 26 68.3 (65.0-71.4) 13 68.8 (65.2-72.1) 28
Illinois 78.4 (77.9-78.8) 36 81.5 (80.6-82.3) 23 67.5 (64.4-70.3) 28 69.8 (66.4-72.7) 16
Indiana 78.7 (78.1-79.3) 31 79.6 (77.9-81.2) 42 67.1 (63.8-70.1) 33 67.3 (63.8-70.6) 43
Iowa 80.6 (80.1-81.1) 6 81.9 (80.8-83.1) 16 69.5 (66.4-72.4) 5 70.2 (66.8-73.4) 9
Kansas 80.1 (79.5-80.7) 10 80.9 (79.1-82.5) 30 68.7 (65.5-71.7) 7 69.1 (65.7-72.4) 23
Kentucky 78.1 (77.5-78.6) 42 78.4 (77.3-79.4) 46 66.1 (62.8-69.1) 48 65.8 (62.2-69.1) 50
Louisiana 77.1 (76.6-77.7) 50 78.4 (77.4-79.4) 47 65.7 (62.5-68.7) 50 66.6 (63.2-69.8) 47
Maine 79.5 (79.0-80.0) 22 81.5 (80.7-82.4) 22 68.2 (65.0-71.1) 15 69.6 (66.3-72.8) 18
Maryland 78.1 (77.7-78.6) 40 81.5 (80.6-82.4) 21 66.7 (63.5-69.7) 38 69.2 (65.8-72.4) 22
Massachusetts 79.8 (79.2-80.2) 15 82.7 (81.8-83.6) 6 68.0 (64.8-71.0) 19 70.3 (66.8-73.7) 5
Michigan 78.4 (78.0-78.8) 34 80.4 (79.5-81.4) 37 66.9 (63.7-69.9) 35 68.3 (64.9-71.4) 36
Minnesota 80.9 (80.5-81.4) 3 82.9 (81.8-83.9) 4 69.9 (66.7-72.7) 2 71.4 (68.3-74.5) 2
Mississippi 77.2 (76.6-77.8) 49 77.7 (76.1-79.6) 51 66.5 (63.5-69.2) 43 66.8 (63.7-70.0) 46
Missouri 79.0 (78.5-79.4) 27 79.9 (79.0-80.9) 39 67.6 (64.3-70.5) 26 67.9 (64.5-71.0) 40
Montana 79.7 (79.0-80.4) 17 81.0 (79.4-82.5) 28 68.1 (64.9-71.1) 18 68.8 (65.2-72.2) 29
Nebraska 80.1 (79.6-80.6) 7 81.8 (80.8-82.7) 17 68.9 (65.7-71.9) 6 70.0 (66.6-73.0) 11
Nevada 78.0 (77.5-78.5) 43 80.5 (79.5-81.7) 35 66.6 (63.4-69.5) 41 68.2 (64.7-71.4) 37
New Hampshire 79.7 (79.2-80.1) 18 82.2 (81.4-83.0) 13 68.0 (64.7-71.0) 20 69.9 (66.2-73.0) 12
New Jersey 78.5 (78.1-79.0) 32 82.4 (81.4-83.5) 8 67.4 (64.2-70.3) 30 70.2 (66.8-73.4) 8
New Mexico 79.4 (78.8-80.1) 24 80.7 (79.1-82.3) 33 67.5 (64.2-70.6) 27 67.9 (64.3-71.5) 39
New York 78.3 (77.8-78.9) 38 82.7 (81.3-84.2) 5 66.7 (63.4-69.8) 39 69.7 (65.9-73.3) 17
North Carolina 78.4 (77.9-78.8) 35 80.3 (79.5-81.2) 38 67.4 (64.3-70.2) 29 68.8 (65.4-71.7) 30
North Dakota 81.3 (80.6-82.0) 2 82.6 (81.3-83.9) 7 69.8 (66.5-72.7) 3 70.3 (66.8-73.6) 7
Ohio 78.5 (78.1-79.0) 33 79.9 (79.1-80.7) 40 66.8 (63.5-69.9) 37 67.4 (63.9-70.5) 41
Oklahoma 78.3 (77.9-78.8) 37 78.2 (77.2-79.2) 48 66.6 (63.3-69.6) 42 65.8 (62.3-68.9) 49
Oregon 79.4 (79.0-79.9) 23 81.7 (80.8-82.6) 19 68.0 (64.8-70.9) 21 69.5 (66.3-72.7) 19
Pennsylvania 78.7 (78.3-79.1) 29 81.0 (80.2-81.9) 27 66.9 (63.6-70.0) 36 68.4 (64.7-71.6) 35
Rhode Island 79.7 (79.1-80.3) 20 82.0 (80.7-83.3) 14 67.8 (64.5-70.8) 23 69.4 (65.8-72.9) 20
South Carolina 77.4 (76.8-78.1) 48 79.4 (77.7-80.9) 43 66.1 (62.9-69.0) 49 67.3 (63.7-70.6) 42
South Dakota 80.6 (80.0-81.2) 5 81.6 (80.1-83.0) 20 69.5 (66.3-72.4) 4 69.8 (66.4-72.9) 15
Tennessee 78.1 (77.7-78.6) 41 78.8 (77.8-79.7) 44 66.7 (63.6-69.6) 40 66.9 (63.4-70.1) 45
Texas 79.0 (78.5-79.5) 26 80.9 (79.8-81.9) 31 67.7 (64.5-70.6) 24 68.6 (65.2-71.9) 31
Utah 80.8 (80.3-81.2) 4 81.4 (80.5-82.2) 24 68.7 (65.2-71.7) 8 68.8 (65.3-71.9) 27
Vermont 79.8 (79.3-80.3) 13 82.2 (81.2-83.3) 12 68.5 (65.3-71.4) 10 70.3 (67.0-73.5) 6
Virginia 78.7 (78.3-79.2) 30 81.3 (80.4-82.1) 25 67.2 (64.0-70.2) 32 69.0 (65.6-72.1) 26
Washington 79.8 (79.3-80.3) 14 82.3 (81.4-83.2) 10 68.3 (65.0-71.2) 14 70.0 (66.4-73.2) 10
West Virginia 78.0 (77.5-78.5) 44 77.9 (76.8-78.9) 50 66.2 (62.9-69.1) 47 65.5 (61.9-68.5) 51
Wisconsin 80.0 (79.6-80.5) 12 81.7 (80.8-82.5) 18 68.6 (65.4-71.5) 9 69.8 (66.3-73.0) 14
Wyoming 79.6 (78.8-80.3) 21 80.8 (79.3-82.2) 32 68.1 (64.8-71.1) 17 68.6 (64.9-71.9) 33
Washington, DC 74.6 (73.9-75.3) 51 80.6 (79.1-82.2) 34 63.9 (60.8-66.6) 51 69.1 (65.6-72.6) 24
Abbreviation: UI, uncertainty interval.
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declined in all states. The most pronounced declines were in
South Carolina, Georgia, Alaska, andNewYork, at higher than
a0.85-pointdecrease inprobability (Figure3). Incontrast,Maine
had the lowest decline of 0.32-point probability. In the United
States as awhole, therewas a decline of 0.70,whichwas asso-
ciatedwithneonataldisorders,othernoncommunicablediseases
(includingcongenital),andalargecontributionfrominjuries,with
slight increases from mental and substance use disorders
(Figure 3).
The largest reductions inprobabilityofdeath for ages20 to
55yearswereobservedinNewYork(3.5)andCalifornia (2.5)and
the highest increases were observed inWest Virginia (2.6) and
Oklahoma (2.0) (Figure4). In 21 states, theprobability of death
has actually increased from 1990 to 2016, but of these, only 5
showedan increase of greater than 10% (Kentucky,Oklahoma,
NewMexico,WestVirginia,andWyoming).Conversely,31states
andWashington, DC have seen decreases in the probability of
deathamongadultsaged20to55yearsoverthesameperiod,but
onlyin15stateswasthatdecreasemorethan10%(NewYork,Cali-
fornia, Illinois,NewJersey,Georgia,Maryland,Florida,Nevada,
Texas, Virginia, Connecticut, North Carolina, Massachusetts,
Washington, South Carolina). Decreases in the probability of
deathinUSstateswereinfluencedbydeclines inHIV/AIDSacross
allstategroups,aswellasdeclinesinroadinjuriesandneoplasms,
while increases in probability of death were influenced by in-
creasedburdenofdrugusedisorders,alcoholusedisorders,and
chronic kidney disease, among others (Figure 4).
All states experienced a considerable reduction in prob-
abilitiesofdeath for ages55 to90years, largelyassociatedwith
reductions in theprobability ofdying fromcardiovascular dis-
eases (Figure5).Thehighestpointdeclinewasobserved inCali-
forniaat 12.6points, comparedwith lowestdeclineof3.5points
for Mississippi. These declines were somewhat offset by in-
creases in the death rates associated with cirrhosis and other
liver disease, neurological disorders, and mental and sub-
stance use disorders in all states. Hawaii was the only state in
which the probability of death was less than 65% for ages 55
to90years.Othernotable findings include thevariation in the
decline of probability of death between the 3 age groups,with
an 8.3-point decline of probability of death for ages 55 to 90
years, a 1-point decline for ages 20 to 55 years, and a0.7-point
decline for ages 0 to 20 years.
YLLs Overall, by State, and forWashington, DC
Theage-standardizedYLL rates for theUnitedStates, all states,
andWashington, DC in 2016 for the top 20 causes are grouped
by3 levelsof significance (Figure6) indicating significantlybe-
lowthemean, indistinguishablefromthemean,andsignificantly
higherthanthemean.Theheatmapshowsaclearpatternofper-
formancerangingfromMinnesotatoMississippi,withsomeclear
patternsofexceptionforsomecauses.Forexample,Coloradohad
a YLL rate from self-harm significantly above themean (760),
whileWashington,DChadaYLLratesignificantly lowerthanthe
mean (306). Mississippi, West Virginia, Alabama, Oklahoma,
Kentucky, Tennessee, South Carolina, Indiana, Missouri, and
Ohio had YLLs significantly higher than the mean with a few
exceptions of causes that were indistinguishable from the
mean.Othernotable findingswere thatLouisianahadYLLs forTa
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Figure 3. Change in the Probability of Death Between Birth and Age 20 Years, 1990-2016, Reported ShowingMajor Causes of Death
for the United States Overall and the 50 States
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Figure 4. Change in the Probability of Death Between Ages 20 and 55 Years, 1990-2016, Reported ShowingMajor Causes of Death
for the United States Overall and the 50 States
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Figure 5. Change in the Probability of Death Between Ages 55 and 90 Years, 1990-2016, Reported ShowingMajor Causes of Death
for the United States Overall and the 50 States
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all causeshigher than thatof theUSmeanexcept forAlzheimer
diseasesandotherdementias thatwassignificantlyhigher than
themean,whileGeorgiahadonly1cause,drugusedisorder, that
was significantly above theUSmean.
Figure 6. Age-Standardized Rates of Years of Life Lost per 100000Persons for the 20 Leading Causes of Years of Life Lost in 2016
for the United States Overall, the 50 States, and the District of Columbia
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Observed to Expected YLLsOverall, by State, and forWashington, DC
The ratioof observedYLLs to those expected, basedon theSDI
for the 10 leading causes of YLLs for the United States overall,
each individual state, and Washington, DC, are shown in
Figure 7. For example, in Alabama, the stroke ratiowas 1, indi-
cating that the observed rates are similar towhatwould be ex-
pectedgiventhestate’sSDI,whereasdiabetes isobservedat2.85
timesmore thanexpected.For theUnitedStatesoverall, the ra-
tios of observed YLLs to those expectedwere 0.75 for IHD, 1.11
for lung cancer, 1.88 for chronic obstructive pulmonary dis-
ease,0.61 for stroke, 1.19 for road injury, 1.14 forAlzheimerdis-
ease, 0.98 for self-harm, 7.17 for drugs, 0.84 for colorectal can-
cer,and1.27for lowerrespiratorytract infection. Ingeneral,most
statesperformedbetteron IHDandstrokebutworse forchronic
obstructive pulmonary disease and drug use disorders. Colo-
rado had the best performance for IHD at 0.58 observed to ex-
pected ratio of YLLs, while West Virginia had the highest ob-
served toexpected ratioofYLLs fordrugusedisorders at 14.38.
Othernotable findings are thehigh rates inWashington,DC for
interpersonal violence, drug use disorders, HIV/AIDS, and
chronickidneydisease,giventhatWashington,DChasthehigh-
est SDI rank in the US and in the world.
Observed to Expected YLDs by State and forWashington, DC
The ratio of the YLDs observed to those expected based on SDI
forthe10leadingcausesofYLDsfortheUnitedStatesoverall, the
50states,andWashington,DCareshowninFigure8.Minnesota
had lowerobservedYLDs fromlowbackandneckpain (0.63 ra-
tio)andmigraine (0.79),buthigherYLDrates fromdrugusedis-
orders(2.32).MoststateshadlowerthanexpectedYLDsfromlow
back and neck pain but higher rates for drug use disorders and
othermusculoskeletaldisorders.Anotable finding is thehigher
thanexpected rates ofYLDs fromdepression, anxiety, and skin
diseases,andlowerthanexpectedrates fromfalls inmoststates.
Observed to Expected DALYs by State and forWashington, DC
The ratio ofDALYsobserved to those expectedbasedonSDI for
the 10 leading causesofDALYs for theUnitedStatesoverall, the
50 states, andWashington, DC are shown inFigure 9. All states
hadlowerthanexpectedDALYratesfromIHDexceptforAlabama,
Arkansas,Kentucky,Mississippi,Oklahoma,Tennessee,andWest
Virginia.ThehighestobservedratesofDALYscomparedwithex-
pected fromdrugusedisorderswere inWestVirginiaat7.77and
inKentuckyat7.31.Othernotablefindingsarethehigherthanex-
pected ratesofdrugusedisordersand interpersonalviolence in
Washington,DC,andthe lower thanexpected ratesof lungcan-
cer in California.
Changes in Age-Standardized Summary Exposure Values
Theage-standardizedpercentchangesinsummaryexposureval-
ues for the top 10 risk factors from 1990 to 2016 are shown in
Table7.High fastingplasmaglucose increasedby76%andhigh
bodymassindexby53.2%,whilesmokingdeclinedby42.8%dur-
ing the same timeperiod in theUnited States. Therewere clear
patterns in these variations by states. High fasting plasma glu-
cose increased in all states; the increase ranged from 127.2% in
Mississippi to 1.7% in Pennsylvania. Drug use increased in all
states except Arkansas, Maryland, and Oregon. Other notable
findings includereductions inhighsystolicbloodpressure,high
total cholesterol levels, anddiet lowinwholegrains inall states.
Leading Risk Factors for DALYs by State and forWashington, DC
The rankof risk factors by state in2016are shown inFigure 10.
Tobacco smoking was the leading risk factor for DALYs in the
United States and in 33 states. Alcohol and drug use were the
leading risk for DALYs for 7 states andWashington, DC, while
high BMIwas the leading cause for 10 states (California, Con-
necticut, Hawaii, Illinois, Maryland, New Jersey, New York,
North Dakota, Texas, and Virginia). Another notable finding
is that diet was the third leading cause of DALYs in the United
States overall but the second in 20 states.
Discussion
This study provides a comprehensive report on the burden of
disease and its patterns in theUnited States and the individual
50states from1990to2016and revealswidedisparities inbur-
denofdiseaseat the state level.Moreover, these findings show
distinct trends indifferent agebandsanddemonstrate that im-
provement in some health outcomes, such as IHD, lung can-
cer, and neonatal preterm complications, are balanced by ris-
ing death rates from drug use disorders, chronic obstructive
pulmonary disease, self-harm, chronic kidney disease, cirrho-
sis, and hypertensive heart disease. Summarymeasures, such
as life expectancy, thatdonotdifferentiate the trends indiffer-
entagegroupsmasktheheterogeneousdirections forUShealth
status by age and state. Above andbeyond thedrivers of diver-
gent trends, the study reveals that there has been far greater
progress in reducing theburdenof somemajor causes ofYLLs,
suchas IHDandlungcancer,butnoprogress inaddressingsome
of the leading causes of YLDs such as mental health disorders
andmusculoskeletal disorders. These findings should be used
to examine the causes of health variations and to plan, de-
velop, and implementprogramsandpolicies to improvehealth
overall and eliminate disparities in the United States.
Mortality reversals in21 states for adults ages20 to55years
arestrongly linkedtotheburdenofsubstanceusedisorders, cir-
rhosis, and self-harm, and this study shows that the trends for
some of these conditions differ considerably across different
states. Case and Deaton have called some of these conditions
“deathsofdespair”andargued that theyare linked to thesocial
andeconomic statusofwhiteUSadults.3Awide rangeof inter-
ventionshavebeenproposedtoaddresssubstanceabuse,cirrho-
sis, andself-harm.For substanceabuse,28,47-49preventionpro-
grams should account for the root causes of substanceuse, the
socioeconomic factors involved, and causes of relapses during
treatment.50,51 Physicianshaveamajor role toplay inaddiction
control by counseling their patientswho are onmedication for
pain control.52-54 For cirrhosis, intervention strategies to treat
hepatitisCanddecreaseexcessivealcohol consumptionare im-
portant.For self-harm, themostpromisingapproaches relate to
decreasingthecase-fatalityratefromsuicideattemptsbyrestrict-
ing access to lethalmeans; in theUnited States, a large share of
suicides are due to firearms.55,56 While multiple strategies are
availablefordealingwiththeseproblems,theyhavenotuntilvery
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Figure 7. Ratio of Observed Years of Life Lost (YLLs) to Expected YLLs Based on the Sodiodemographic Index (SDI) for the United States Overall,
the 50 States, and the District of Columbia in 2016 for the 10 Leading Causes in Each Jurisdiction
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for explanation of terms.
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Figure 8. Ratio of Observed Years LivedWith Disability (YLDs) to Expected YLDs Based on the Sociodemographic Index (SDI) for the United States
Overall, the 50 States, and the District of Columbia in 2016 for the 10 Leading Causes in Each Jurisdiction
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See Figure 7 caption for details. See Appendix Table 2 in Supplement 2 for explanation of terms.
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Figure 9. Ratio ofObservedDisability-Adjusted Life-Years (DALYs) to ExpectedDALYs Based on the Sociodemographic Index (SDI) for theUnited States
Overall, the 50 States, and theDistrict of Columbia in 2016 for the 10 Leading Causes in Each Jurisdiction
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(0.88)
Skin
(1.12)
Other MSK
(2.61)
Skin
(1.24)
Depression
(1.4)
Alzheimer
(1.36)
Depression
(1.37)
Skin
(1.15)
Alzheimer
(1.35)
COPD
(1.7)
Road injury
(1.27)
Alzheimer
(1.13)
Self-harm
(1.48)
Sense organ
(0.87)
Skin
(1.1)
Skin
(1.1)
Depression
(1.21)
Alzheimer
(1.38)
Road injury
(1.31)
CKD
(3.14)
Alzheimer
(1.13)
Depression
(1.33)
Stroke
(0.59)
Drugs
(3.08)
Depression
(1.41)
Skin
(1.22)
Skin
(1.15)
Depression
(1.32)
Alzheimer
(1.17)
Depression
(1.39)
Depression
(1.16)
Stroke
(0.62)
Drugs
(3.01)
Road injury
(1.26)
Alzheimer
(1.4)
Stroke
(0.49)
Depression
(1.32)
Stroke
(0.57)
Road injury
(1.08)
Lung cancer
(0.68)
Depression
(1.47)
Stroke
(0.58)
COPD
(1.56)
Skin
(1.11)
Depression
(1.29)
Ratio of
observed to
expected
DALYs
(0.0-0.66)
(0.67-0.83)
(0.84-0.95)
(0.96-1.10)
(1.11-1.22)
(1.23-1.44)
(1.45-1.81)
(1.82-2.56)
>2.56
See Figure 7 caption for details. See Appendix Table 2 in Supplement 2 for explanation of terms.
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recently garnered attention. The increases in these causes of
deathhavebeenunderwayfor20years,but theUShealthpolicy
communityhasbeenslowtorecognizethisrisingsetofproblems.
This study shows that high BMI, smoking, and high fast-
ingplasmaglucose are the 3most important risk factors in the
United States, and that although smoking is decreasing, BMI
Figure 10. Ranking of Risk Factors in 2016 for the United States Overall, the 50 States, and the District of Columbia According to the Number
of Disability-Adjusted Life-Years Related to Each Risk Factor
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and fastingplasmaglucose levels are steadily increasing.These
2 risk factorsposeuniquechallenges in theUnitedStates given
thatunabated, theyhave thepotential tochange thehealth tra-
jectory for individuals inmanystates.Levelsofoverweightand
obesity increased during the study period. US residents need
todomore tomaintain theirweightor reduce it,whenneeded,
as well as access systems to support these intentions.57 Al-
thoughphysical activity increasedduring thestudyperiod, the
levels of increase were not enough to control weight gain.8
Physical inactivity is a risk factor for many diseases, but in-
creasing activity is not enough on its own to reduceweight or
preventweightgain.58Obesity is associatedwith increaseddia-
betes, cardiovascular diseases, some neoplasms, and poor
health-related quality of life. This study calls for renewed ef-
forts to control weight gain at the community level.
Several studieshave reportedon theeffect of taxesonsug-
ary drinks or subsidies to encourage consumption of healthy
foods, although only a small fraction of obesity can be linked
to sugar-sweetened beverages.59 A comprehensive plan is
needed to address obesity because it adversely affects health
anddrivesuseofhealthcare resources.4,60-62RisingBMI isdriv-
ing up fasting plasma glucose levels and diabetes, and diabe-
tes increased as a cause of burden in almost all states during
the study period. Diabetes is a costly disease that consumes
approximately 4.82% of the US health care budget.4 A recent
studyestimated that thecostofdiabetescare increasedby6.1%
from 1996 to 2013.4 Diabetes is associated with many condi-
tions anddisabilities.63 This rise in burdenand its cost is note-
worthy given the projected increase in diabetes as obesity in-
creases in the United States.
This study shows that there were reductions in the death
rates fromcardiovasculardiseases for all agegroups.Thisprog-
resshasbeen, inpart, influencedbyreductions insystolicblood
pressure and cholesterol, but the role of increased access to ef-
fective treatment has also been considerable.64 In fact, age-
standardizedCVDdeathrateshavedecreasedintheUnitedStates
by32.8%over the last20years.The important roleof treatment
inreducingdeathrateshighlights theongoing importanceofen-
suring financial andphysical access to careand the importance
ofqualityof care.Asdeclines in the rateofCVDmaybeslowing
down,adverse trendsduetothediseasesofdespairandadverse
risktrendsmaymeanthathistoricalprogress in improvedlifeex-
pectancymay not continue in the future.
Thestrategiesfordealingwiththeremaininginequalitiesand
new threats are 3-fold: (1) address some of the key modifiable
risks, includingdiet; tobacco,alcohol,anddruguse; insufficient
physical activity; and obesity; (2) improve access to and,more
importantly,qualityof care inkeyareas, suchaschronickidney
diseaseandongoingcare forsubstanceusedisorders;and(3)ad-
dress the social determinants of health. We have previously
shownanassociationbetweensocioeconomicandrace/ethnicity
factors anda60%county-level variation in life expectancy, be-
havioral and metabolic risk factors and a 74% variation, and
healthcare factors anda27%variation.65Combined, these fac-
torsareassociatedwith74%ofoverallvariation.Wealsoreported
thatmost of the association between socioeconomic and race/
ethnicity factorsand lifeexpectancywasmediated throughbe-
havioral and metabolic risk factors. Research has shown that
someenvironmental factorshave aneffect on risk factors such
asobesityandlowphysicalactivity.Lowsocioeconomicsettings
oftenhaveanimbalanceoffewgrocerystoresandnumerousfast
food options, and access to safe outdoor places spaces for rec-
reation is limited.66,67
To date, the strategies for addressing the social determi-
nants of health in the United States have been elusive. Lack
of progress and rising social inequalities should not engender
complacency. Therefore, addressing risk factorsmayprove to
bean importantopportunity to reducedisparitiesanddealwith
some of the challenges for improving US health. Opportuni-
ties to decrease the burden of disease through reducing to-
bacco, alcohol, drug use, blood pressure, and cholesterol; in-
creasingphysical activity; and improvingdiet emphasize that
the United States should invest more in prevention that tar-
gets these risks.To increase the likelihoodofprevention tosuc-
ceed, it has to be a priority for all stakeholders—physicians,
nurses,hospital systems,policymakers,health insurancecom-
panies, patients and their families, and advocacy groups.
This studyshowedawide rangeof challengesencountered
bydifferentstatesandbysomecountieswithinstates.Giventhe
diversityofrisks,communities,andworkplacesthereisnosimple
menuofeffectiveprograms for risk reduction. Indeed, local ex-
perimentation todeterminewhatworks in a given community
is likely to be necessary. There is a need to change strategies of
fundingandevaluationof innovative interventionsandpolicies,
andindependentevaluationofwhethertheseeffortsworkornot
shouldbedocumented.Tosucceed, these innovativeprograms
should forge a connection between health care provision and
progress for individuals and communities in health outcomes.
Thenotionof accountability shouldbebroadenedbeyondpro-
vidinghigh-quality care toencompassachieving risk reduction
in partnershipwith patients and communities.
The interpersonal violenceburden in theUnitedStateshas
to be properly addressed, although declines have been ob-
served: theage-standardizeddeathratedecreased32.43%from
1990 to 2016 in theUnited States. However, self-harmby fire-
arm accounted for 6.39 deaths per 100000 persons in the
United States in 2016, and physical violence by firearm ac-
counted for 3.98 deaths per 100000 persons. There is evi-
dence that gun control achieved through background checks
reduces homicide and suicide.68-72 Previous studies reported
success in reducing the burden of gun deaths through policy
changes inBrazil andother countries.71 Indeed, enforcing gun
control policies has proven effective in reducing mortality in
a variety of contexts. There is a need for comprehensive stud-
ies of the epidemiology of gun violence in the United States
to inform the ongoing gun control debate.
Age-standardized death rates due to alcohol increased by
17.50% from1990 to2016 in theUnited States, andalcohol use
disordersaccountedfor2.89deathsper100000personsin2016.
Previousstudieshaveshownthatalcoholconsumptionandbinge
drinkinghave increased in theUnitedStates, especially among
females.6,73Alcohol isamajorriskfactor forburdenintheUnited
States10andisassociatedwithadverseoutcomesincludingsexu-
ally transmitted diseases, violence, and accidents.16 Traffic in-
jurieshavereceivedaconsiderableamountofattention,but the
true burdenof alcohol ismuchbigger and goes beyonddriving
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while intoxicated. Programs to educateUS residents about the
true harms of excessive drinking are needed.
Many of the risk factors that contribute to the disparities
in burden are amenable tomedical treatmentwithin the con-
text of supportive behavioral and lifestyle changes. For ex-
ample, many cardiovascular risk factors, such as high blood
pressure andhigh cholesterol levels, cannowbe treatedmore
effectivelywithearlydetectionandproper follow-up. Safe, ef-
fective, and affordable antihypertensivemedications arenow
widely available, often as generic preparations, especially at
discountpharmacies, and inmanycases,without theneed for
health insurance for medications. The Affordable Care Act
(ACA) allows for the expansion of insurance coverage, which
ultimately increases access to care. Indeed, the ACA expan-
sion of Medicaid coverage in participating states to all nonel-
derly adults with incomes below 133% of the federal poverty
level provides an opportunity for early detection and fol-
low-upof someof themainhealth risk factors.However,many
US residents donot havehealth insurance, even after theACA
was introduced, and hence have little access tomedical diag-
nosis and treatment.Therefore, expandinghealth coverage for
certain conditions andmedications shouldbe considered and
adopted to reduce burden.
This studyshowed that theUnitedStatesoverall andmany
individual stateshavemadeprogress in reducingmortalitybut
have had limited success in reducing disability. For instance,
the burden of drug use disorders in total DALYs increased in
the United States during the study period by 61.4% and ac-
counted for about 3.81million DALYs in 2016, depressive dis-
orders increased 17.32%andaccounted for 2.72millionDALYs,
and anxiety disorders increased by 16.7% and accounted for
approximately 1.76millionDALYs in2016.These findingspoint
to an urgent need to address mental health and drug use dis-
orders in the United States. There is a need for improved ac-
cess to quality mental health care and screening to improve
outcomes, aswell asprograms topreventmentaldisorders and
promote mental health.
As the US population ages, the burden of musculoskel-
etal disorders will increase. More US residents have neck and
back pain, and the incidence of falls is increasing. Musculo-
skeletaldisordersareassociatedwithahighmedical cost.4Pre-
ventivemeasures to reduce the burdenof these risk factors in
all stages of life are urgently needed. Programs for avoiding
harmand injuries atwork amongbothyounger andolder ages
are needed. The programs should include prevention of falls
in theolderpopulation throughexamining the risk factors that
lead to falls among adults. Screening tools and interventions
to address this burden should be implemented.
TheresultsofGBD2016haveshownthatoccupational risks
and air pollution were the 9th and 10th leading causes for
DALYs. Although the findings show reductions in attribut-
able burden from 1990 to 2016, occupational risks still ac-
count for 948.75 DALYS per 100000 persons, and air pollu-
tion accounts for 584.97 DALYs per 100000 persons—large
numbers in the United States. Indeed, renewed efforts to re-
duce the burden of environmental and occupational risks are
needed to ensure continued progress in reducing their effect
on health in the United States.
Several studies have shown that poor diet is amajor chal-
lenge in the United States, and little improvement has oc-
curred over the past decades. US residents are not consuming
a healthy diet; they tend to consume more calories than
needed, and composition is not ideal.49,62 Some recent stud-
ies have shownmodest improvement in certain aspects of US
diet, especiallydecreases inconsumptionof sugarydrinks.The
United States needs a comprehensive program to improve di-
etary intake at national and local levels. This program should
offer financial incentives and disincentives for more vs less
healthful foodproducts by agricultureproducers, foodmanu-
facturers, and retailers, as well as for choices by consumers.
Thiseffort shouldalso implementcomprehensivewellnesspro-
grams in schools,workplaces, andgovernmentoffices, and in-
form the public of the importance of a healthful diet.
Limitations
Given the scope of this analysis, this study has several impor-
tant limitations. The overall limitations of the GBDmethods,
as noted in other publications, apply to the US analysis. First,
theaccuracyof theestimatesdependsontheavailabilityofdata
by time period and state. Second, it is challenging to separate
measurement error fromvariation indiseaseoccurrence.GBD
corrects for known bias from nonreference methods or case
definitions,butoftenhas to relyonsparsedataat thestate level
to make those adjustments. Third, GBD applies garbage code
redistribution for 13%of causes of deaths in theUnited States;
this ranged from 8.4% in South Dakota to 21.3% in Alabama.
Therefore, the causes of death may not match those in other
publications but aremore robust because they control for the
between-states variation in the prevalence of garbage codes.
Fourth, GBD methods adjust for hospital admissions using a
largenonrepresentativesourceofmedical claimsdata.Thegen-
eralizability of claims data, the use of primary diagnosis only
or all diagnostic fields, and the trendsof claimsdatahavebeen
questioned.13Also, theremaybeconsiderable interstatevaria-
tion in how diseases are treated between inpatient and out-
patient settings. GBD methods adjust for such potential bi-
asesbyusingacovariateonclaimsandhospitaladmissionsdata
to correct for systematic error. Fifth, GBD includes risk-
outcomepairs thatmeet theWorldCancerResearchFund cri-
teriaof causality.However, somerisk-outcomepairsmightnot
meet criteria thatdevelopasevidence fromnewstudies ispub-
lished. Sixth, there is limited information on dietary intake at
the state level. The Behavioral Risk Factors Surveillance Sys-
temhas6dietaryquestionsattemptingtocapture fruitandveg-
etable consumption. Therefore, GBD 2016 used commercial
sales data to adjust estimates of dietary intake. Seventh, some
of the data used in the analyses have a lower quality and con-
sistency across states and age groups. GBD 2016 reports 95%
UIs toshowtheeffectof this limitationontheestimates.Eighth,
the study reports disparities between states but does not ex-
amine the within-state variations of burden, which could be
substantial, especially in large states. Ninth, claims datawere
only available through 2012 at the time of these analyses. Ad-
ditionally, this study does not report the burden of the social
determinants of health; it focuses only on behavioral, envi-
ronmental, and metabolic risks.
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Conclusions
There are wide differences in the burden of disease at the
state level. Specific diseases and risk factors, such as drug
use disorders, high BMI, poor diet, high fasting plasma
glucose level, and alcohol use disorders are increasing and
warrant increased attention. These data can be used to
inform national health priorities for research, clinical care,
and policy.
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